Please login to the form below

Not currently logged in
Email:
Password:

Senior changes for Forest and Amarin

Dr Lawrence S Olanoff is to retire as president of Forest Laboraties, while Joseph S Zakrzewski is to become CEO of Amarin Corporation

Forest Laboratories has announced the retirement of its president and chief operating officer, Dr Lawrence S. Olanoff, effective December 31, while Amarin Corporation has announced that Joseph S Zakrzewski, an experienced biotech executive, has been appointed as its chief executive officer, effective immediately.

Olanoff, who was president of Forest Research Institute before taking his current role, will stay on as a member of the board of directors at Forest and will become senior scientific advisor, spending at least one week a month working at the company, with his primary focus being on drug-development activities.

Howard Solomon, chairman and CEO of Forest, will additionally take on the role of president of the company after Olanoff's retirement.

Separately, at Amarin, Zakrzewski will continue as chairman of the board, a role he has held since January of this year, and will also lead the company as CEO. Earlier in his career, Zakrzewski served as chief operating officer at Reliant Pharmaceuticals in the period leading up to the company's 2007 acquisition by GlaxoSmithKline (GSK). Most recently, he was chief executive officer of Xcellerex, a privately held biotech company.

Zakrzewski succeeds Colin Stewart, who resigned as president and CEO of the company effective November 10 "to address personal matters." Stewart, a former president and CEO of CollaGenex Pharmaceuticals, led Amarin for only a few months before resigning.  Amarin announced his appointment in August of this year.

John F Thero, who has been the company's chief financial officer since late last year, will replace Stewart as president of Amarin.   Prior to joining Amarin, Thero was chief financial officer at ViaCell and Abiomed.

11th November 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics